Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Meningioma × regorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 58 Carcinoma, Hepatocellular 20 Neoplasm Metastasis 14 Rectal Neoplasms 9 Colonic Neoplasms 8 Gastrointestinal Stromal Tumors 7 Sarcoma 5 Ovarian Neoplasms 5 Glioblastoma 5 Stomach Neoplasms 4 Osteosarcoma 4 Melanoma 4 Pancreatic Neoplasms 3 Liver Neoplasms 3 Leukemia, Myeloid, Acute 3 Esophageal Neoplasms 3 Colorectal Cancer Metastatic 3 Cholangiocarcinoma 3 Carcinoma, Non-Small-Cell Lung 3 Thyroid Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Hematologic Neoplasms 2 Gastrointestinal Neoplasms 2 Gallbladder Neoplasms 2 Fatigue 2

Interventions

Magnetic Resonance Spectroscopy 11 gallium Ga 68 dotatate 6 Everolimus 6 lutetium Lu 177 dotatate 5 Radiosurgery 5 Proton Therapy 5 pembrolizumab 4 Surveys and Questionnaires 4 Specimen Handling 4 Hydroxyurea 4 abemaciclib 3 Tranexamic Acid 3 Surgical Procedures, Operative 3 Ga(III)-DOTATOC 3 Bevacizumab 3 trametinib 2 arginyllysine 2 Yoga 2 Whole Body Imaging 2 Sunitinib 2 Sodium Chloride 2 Radiotherapy 2 Protons 2 Observation 2 Mental Status and Dementia Tests 2 Magnetic Resonance Imaging 2 Imatinib Mesylate 2 Gadolinium DTPA 2 Fluorodeoxyglucose F18 2 Filgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06275919 2025-03-13

MIRAGE

Istituto Oncologico Veneto IRCCS

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡